Biocom’s Annual Global Life Science Partnering Conference : 2019
Algomedix will be attending and holding partnering meetings at Biocom’s Annual Global Life Science Partnering Conference, February 27-28, 2019 in La Jolla, California.
Wilson Sonsini Goodrich and Rosati (WSGR) Healthcare Investment Forum
Algomedix has been selected to participate in the 4th Wilson Sonsini Goodrich and Rosati (WSGR) Healthcare Investment Forum in Palo Alto, California which is taking place on November 7th and 8th, 2018. The WSGR Investment Forum presents an opportunity for life science venture investment firms to connect with promising start-ups to discuss potential funding.
Bio-Japan/Regenerative Medicine 2018: Partnering Conference
Algomedix will be holding partnering meetings at Bio-Japan 2018, October 10-12, 2018 in Yokohama, Japan. Dr. Herz will present a talk on October 11th in the Pacifico Yokohama Main Exhibit Hall, Stage A, at 12:05pm describing the Algomedix novel therapeutic for the treatment of chronic pain. Algomedix will also be present at booth C-01 in the Exhibit Hall together with members of Biocom, California.
Biocom’s 8th Annual Global Life Science Partnering Conference : 2018
Algomedix will be holding partnering meetings at Biocom’s 8th Annual Global Life Science Partnering Conference, February 28-March 1, 2018 in La Jolla, California.
J.P. Morgan Healthcare Conference 2018
Algomedix will be attending the JP Morgan Healthcare Conference in San Francisco, California from Jan 8-11th, 2018.
Precision Medicine and Ion Channel Retreat
Algomedix presents at the Precision Medicine and Ion Channel Retreat in 2017 in Vancouver, Canada. Dr. Herz will speak on “Development of a Novel Class of TRPA1 Antagonists as Effective Analgesic Drugs in Multiple Models of Neuropathic Pain” on August 8-11th, 2017.
LSIW: Next-Generation Therapeutics for the Treatment of Pain
Algomedix will present at a meeting: Next-Generation Therapeutics for the Treatment of Pain, a Life Science Washington Special Program, April 27, 2017. Dr. Herz will describe progress in the development of TRPA1 antagonists for the treatment of chronic pain.
Cavendish Global Innovation Partner
Algomedix, a Cavendish Global Innovation Partner, presents at the 3rd San Diego Health Impact Forum in San Diego, California, February 6-8th, 2017.
World Congress on Pain
Algomedix will be attending the World Congress on Pain, October 26-30th, 2016, to be held in Yokohama, Japan.